| HS编码 | 商品名称 | 退税率 | 计量单位 | 海关监管 | 申报要素·检疫 | 编码对比 |
| 30049090.50 | 含右丙氧芬及其盐的复方制剂
[Compound preparations containing dextropropoxyphene and its salts, put up in measured doses, packings for retail sale] |
13% | 千克/无 | I | 查看详情 | -- |
| 30049090.60 | 复方樟脑酊
[Compound camphor tincture (Tincture of opium, camphor, Benzoic acid, oleum anisi stellati), packings for retail sale] |
13% | 千克/无 | I | 查看详情 | 对比-30049090.50 |
| 30049090.71 | 已配剂量含雄甾-4-烯-3α, 17β-二醇（4-雄烯二醇（3α, 17β））的单方制剂
[Single preparation, containing androst-4-ene -3α, 17β- diol , 17β-diol, put up in measured doses, packings for retail sale] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.60 |
| 30049090.72 | 已配剂量含雄甾-5-烯-3α, 17α-二醇（5-雄烯二醇（3α, 17α））的单方制剂
[Single preparation, containing androst-5-ene -3α, 17α-diol, put up in measured doses, packings for retail sale] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.71 |
| 30049090.73 | 已配剂量含雄甾-5-烯-3α, 17β-二醇（5-雄烯二醇（3α, 17β））的单方制剂
[Single preparation, containing androst-5-ene -3α, 17β- diol, put up in measured doses, packings for retail sale] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.72 |
| 30049090.74 | 已配剂量含5α-雄烷-3α, 17α-二醇（阿法雄烷二醇）或雄甾-4-烯-3α, 17α-二醇（4-雄烯二醇（3α, 17α））的单方制剂
[Single preparation, containing α-androstanediol and androstenediol isomer, put up in measured doses, packings for retail sale] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.73 |
| 30049090.75 | 已配剂量含5α-雄烷-3β, 17β-二醇（倍他雄烷二醇）的单方制剂
[Single preparation, containing β-androstanediol and androstenediol isomer, put up in measured doses, packings for retail sale] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.74 |
| 30049090.77 | 含表雄酮（3β-羟基-5α-雄烷-17-酮）的单方制剂
[Single preparation, containing 3β- hydroxyl -5α- androstane -17β-ketone, put up in measured doses, packings for retail sale] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.75 |
| 30049090.78 | 已配剂量含齐帕特罗的单方制剂
[Single preparation, containing zilpaterol, put up in measured doses, packings for retail sale] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.77 |
| 30049090.79 | 已配剂量含表睾酮的单方制剂
[Single preparations containing epitestosterone, put up in measured doses or packings for retail sale] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.78 |
| 30049090.82 | 已配剂量含西布曲明的制剂
[Preparations containing Nitroxinil , Flunixin meglumine and meloxicam , veterinary, put up in measured doses or in forms of packings for retail sale] |
13% | 千克/无 | 9 | 查看详情 | 对比-30049090.79 |
| 30049090.83 | 含1-表雄酮(3β-羟基-5α-雄甾-1-烯-17-酮)的单方制剂
[Single formulation containing 1-epiandrosterone (3β-hydroxy-5α-androgens-1-ene-17-ketone)] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.82 |
| 30049090.84 | 已配剂量兽用制剂 | 13% | 千克/无 | R | 查看详情 | 对比-30049090.83 |
| 30049090.85 | 其他《兴奋剂目录》所列蛋白同化制剂和肽类激素 | 13% | 千克/无 | L | 查看详情 | 对比-30049090.84 |
| 30049090.91 | 含FG-4592（CAS号808118-40-3，一种缺氧诱导因子-脯氨酸羟化酶抑制剂）的已配定剂量的制剂
[With FG-4592(CAS 808118-40-3,a kind of hypoxia inducible factor - prolinehydroxylase inhibitors) have been preparations dosage (including retail wrapping)] |
13% | 千克/无 | Q | 查看详情 | 对比-30049090.85 |
| 30049090.92 | 已配剂量含5α-雄烷-2-烯-17-酮的单方制剂
[A single dose of 5α-androst-2-en-17-one has been formulated] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.91 |
| 30049090.93 | 抗（防）癌药品制剂（不含癌症辅助治疗药品）
[Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs)] |
13% | 千克/无 | Q | 查看详情 | 对比-30049090.92 |
| 30049090.94 | 已配剂量含2-雄烯醇（5α-雄甾-2-烯-17-醇）的单方制剂
[A single dose of a dose containing 2-androstene (5α-androst-2-ene-17-ol) including retail packaging] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.93 |
| 30049090.95 | 已配剂量含3-雄烯醇（5α-雄甾-3-烯-17-醇）的单方制剂
[A single dose of a dose containing 3-androstene (5α-androst-3-ene-17-ol) including retail packaging] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.94 |
| 30049090.96 | 已配剂量含3-雄烯酮（5α-雄甾-3-烯-17-酮）的单方制剂
[A single dose of a dose containing 3-androstenone (5α-androst-3-ene-17-one) including retail packaging] |
13% | 千克/无 | L | 查看详情 | 对比-30049090.95 |